| Bioactivity | MAOA-IN-1 (compound 15) is an orally active MAOA inhibitor with cytotoxicity against prostate cancer cells. MAOA-IN-1 has Caco-2 permeability and lower CNS permeability. MAOA-IN-1 can be further used in the research of anti-cancer and anti-inflammatory indications[1]. |
| Target | Monoamine Oxidase A (MAO-A) |
| In Vivo | MAOA-IN-1 (compound 15) MCE has not independently confirmed the accuracy of these methods. They are for reference only. |
| Name | MAOA-IN-1 |
| Formula | C13H16Cl2N2O2 |
| Molar Mass | 303.18 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jacobs MR, et al. Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration. Bioorg Med Chem. 2023 Sep 7;92:117425. |
MAOA-IN-1 (compound 15) is an orally active MAOA inhibitor with cytotoxicity against prostate cancer cells. MAOA-IN-1 has Caco-2 permeability and lower CNS permeability. MAOA-IN-1 can be further used in the research of anti-cancer and anti-inflammatory indications.
